Search results
Results from the WOW.Com Content Network
For treating gout, the initial effects of colchicine occur in a window of 12 to 24 hours, with a peak within 48 to 72 hours. [26] It has a narrow therapeutic window, requiring monitoring of the subject for potential toxicity. [26] Colchicine is not a general pain-relief drug, and is not used to treat pain in other disorders. [26]
The usual dosage of etifoxine (as the hydrochloride salt) is 150 to 200 mg per day in divided doses of 50 to 100 mg two to three times per day (e.g., 50 mg–50 mg–100 mg). [ 2 ] [ 7 ] [ 6 ] [ 18 ] [ 1 ] [ 19 ] [ 20 ] It is taken for a few days to a few weeks, but no longer than 12 weeks.
While colchicine is not used to treat cancer in humans, it is commonly used to treat acute attacks of gout. [26] Colchicine is an anti-inflammatory drug that has been in continuous use for more than 3000 years. Colchicine is an oral drug, known to be used for treating acute gout and preventing acute attacks of familial Mediterranean fever (FMF).
An anxiolytic (/ ˌ æ ŋ k s i ə ˈ l ɪ t ɪ k, ˌ æ ŋ k s i oʊ-/; also antipanic or anti-anxiety agent) [1] is a medication or other intervention that reduces anxiety.This effect is in contrast to anxiogenic agents which increase anxiety.
B. The tics happen multiple times over the course of the day, almost every day for at least 4 weeks, but do not occur continually for any longer than 1 year. C. Symptoms are present before the age of 18. D. The tics are not a result of any effects due to drug use, or any other medical condition, for example, Huntington's disease. E.
The scale is the "gold standard" for evaluating the effects of psychopharmacological treatments. [ 1 ] [ 2 ] The name refers to the two types of symptoms in schizophrenia, as defined by the American Psychiatric Association : positive symptoms, which refer to an excess or distortion of normal functions (e.g., hallucinations and delusions ), and ...
Eperisone hydrochloride is available as the brand name preparations Myonal and Epry as 50 mg sugar-coated tablets, or as 10% granules for oral administration. [6] An experimental form of the drug, as a transdermal patch system, has shown promising results in laboratory tests on rodents; however, this product is not currently available for human use.
Mianserin at higher doses (30–90 mg/day) is used for the treatment of major depressive disorder. [ 6 ] It can also be used at lower doses (around 10 mg/day) to treat insomnia.